BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16912045)

  • 1. The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanism.
    Liu P; Barkley LR; Day T; Bi X; Slater DM; Alexandrow MG; Nasheuer HP; Vaziri C
    J Biol Chem; 2006 Oct; 281(41):30631-44. PubMed ID: 16912045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
    Guo N; Faller DV; Vaziri C
    Cell Growth Differ; 2002 Feb; 13(2):77-86. PubMed ID: 11864911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
    Sampath D; Shi Z; Plunkett W
    Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of minichromosome maintenance protein 7 (MCM7) by cyclin/cyclin-dependent kinase affects its function in cell cycle regulation.
    Wei Q; Li J; Liu T; Tong X; Ye X
    J Biol Chem; 2013 Jul; 288(27):19715-25. PubMed ID: 23720738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rad18 regulates DNA polymerase kappa and is required for recovery from S-phase checkpoint-mediated arrest.
    Bi X; Barkley LR; Slater DM; Tateishi S; Yamaizumi M; Ohmori H; Vaziri C
    Mol Cell Biol; 2006 May; 26(9):3527-40. PubMed ID: 16611994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
    Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
    J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cdc25A is involved in S-phase checkpoint induced by benzo(a)pyrene.
    Yao B; Fu J; Hu E; Qi Y; Zhou Z
    Toxicology; 2007 Jul; 237(1-3):210-217. PubMed ID: 17602818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein phosphatase 2A antagonizes ATM and ATR in a Cdk2- and Cdc7-independent DNA damage checkpoint.
    Petersen P; Chou DM; You Z; Hunter T; Walter JC; Walter G
    Mol Cell Biol; 2006 Mar; 26(5):1997-2011. PubMed ID: 16479016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage.
    Syljuåsen RG; Sørensen CS; Hansen LT; Fugger K; Lundin C; Johansson F; Helleday T; Sehested M; Lukas J; Bartek J
    Mol Cell Biol; 2005 May; 25(9):3553-62. PubMed ID: 15831461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells.
    Shao RG; Cao CX; Pommier Y
    Acta Pharmacol Sin; 2004 Jun; 25(6):756-62. PubMed ID: 15169628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of MCM3 protein by cyclin E/cyclin-dependent kinase 2 (Cdk2) regulates its function in cell cycle.
    Li J; Deng M; Wei Q; Liu T; Tong X; Ye X
    J Biol Chem; 2011 Nov; 286(46):39776-85. PubMed ID: 21965652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.
    Tu YS; Kang XL; Zhou JG; Lv XF; Tang YB; Guan YY
    Eur J Pharmacol; 2011 Nov; 670(2-3):356-64. PubMed ID: 21958871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Cdc45 in the cell cycle and after DNA damage.
    Broderick R; Nasheuer HP
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):926-30. PubMed ID: 19614620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenopus Drf1, a regulator of Cdc7, displays checkpoint-dependent accumulation on chromatin during an S-phase arrest.
    Yanow SK; Gold DA; Yoo HY; Dunphy WG
    J Biol Chem; 2003 Oct; 278(42):41083-92. PubMed ID: 12897072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition.
    Ditano JP; Sakurikar N; Eastman A
    Cell Cycle; 2021 Jul; 20(13):1308-1319. PubMed ID: 34156324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 regulates cellular responses to environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells.
    Xiao H; Singh SV
    Cell Cycle; 2007 Jul; 6(14):1753-61. PubMed ID: 17630511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of over-expression and suppression of Cdc25A on the S-phase checkpoint induced by benzo(a)pyrene.
    Yao B; Fu J; Hu E; Qi Y; Zhou Z
    Toxicology; 2008 Apr; 246(2-3):180-7. PubMed ID: 18321631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMELESS Suppresses the Accumulation of Aberrant CDC45·MCM2-7·GINS Replicative Helicase Complexes on Human Chromatin.
    Xu X; Wang JT; Li M; Liu Y
    J Biol Chem; 2016 Oct; 291(43):22544-22558. PubMed ID: 27587400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.